Exactus Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
251.50
42.50
72.30
1,055.30
161.20
2
Total Accounts Receivable
0.60
7.60
7.00
-
-
-
Other Current Assets
-
7.40
-
1,019.70
11.50
12.30
Total Current Assets
252.10
57.50
79.40
2,075.10
172.70
14.30
Net Property, Plant & Equipment
28.50
23.70
1.50
-
-
-
Intangible Assets
-
3.60
4.10
50.00
-
-
Total Assets
280.60
84.80
84.90
2,125.10
172.70
14.30
ST Debt & Current Portion LT Debt
-
-
101.20
-
105.80
Accounts Payable
29.30
32.00
75.50
-
-
Income Tax Payable
52.60
-
-
-
-
Other Current Liabilities
5.00
7.00
1.60
625.00
2,282.50
Total Current Liabilities
86.90
39.00
178.20
625.00
2,388.30
Total Liabilities
86.90
39.00
178.20
625.00
2,388.30
Common Equity (Total)
193.70
45.80
93.30
1,498.80
2,217.00
Total Shareholders' Equity
193.70
45.80
93.30
1,500.10
2,215.60
Total Equity
193.70
45.80
93.30
1,500.10
2,215.60
Liabilities & Shareholders' Equity
280.60
84.80
84.90
2,125.10
172.70
Preferred Stock (Carrying Value)
-
-
-
1.30
1.30

About Exactus

View Profile
Address
80 NE 4th Avenue
Delray Beach Florida 33483
United States
Employees -
Website http://www.exactusinc.com
Updated 07/08/2019
Exactus, Inc. is a life science company, which engages in developing and commercializing Point-of-Care (POC) diagnostics for measuring proteolytic enzymes in the blood based on a novel detection platform. It operates under the FibriLyzer and MatriLyzer trademarks. The company was founded on January 18, 2008 and is headquartered in Glen Allen, VA.